Switzerland · Delayed Price · Currency is CHF dormakaba Holding AG Earnings Call Transcripts
Fiscal Year 2026
-
Organic net sales grew 2% and Adjusted EBITDA margin rose to 15.6% amid challenging conditions, driven by cost savings, strong project wins, and six bolt-on acquisitions. Full-year guidance is reiterated, with expectations for stronger H2 volume and margin above 16%.
Fiscal Year 2025
-
Delivered strong organic growth and margin expansion, achieving key financial targets ahead of schedule. Focus remains on U.S. market expansion, cost efficiencies, and innovation, with robust guidance for 2025-2026 and a proposed dividend increase.
-
Strong organic growth and margin expansion were achieved in H1 2024-25, supported by transformation savings, divestments, and targeted acquisitions. Upgraded guidance calls for 3%-5% sales growth and a 15.5% adjusted EBITDA margin for the full year, with continued focus on efficiency and core markets.
Fiscal Year 2024
-
Shape4Growth execution is driving cost savings, complexity reduction, and digital innovation, with a reinforced focus on commercial markets and service growth. Mid-term targets of 3%-5% organic growth and 16%-18% EBITDA margin are reaffirmed, supported by operational streamlining and expansion in the Americas.
-
Strong organic sales growth and margin expansion were achieved, supported by transformation initiatives and robust free cash flow. The outlook targets 3%-5% organic growth and at least 15% EBITDA margin, with continued focus on efficiency, innovation, and disciplined M&A.